Christopher Richard Anzalone Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity
Christopher Richard Anzalone is Chief Executive Officer of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 3.72 Million shares of ARWR, which is worth approximately $72.4 Million. The most recent transaction as insider was on Dec 30, 2020, when has been sold 599 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3.72M
0%
3M change
0.59%
12M change
Total Value Held
$72.4 Million
Christopher Richard Anzalone Transaction History
CRA
Christopher Richard Anzalone
Chief Executive Officer
Pasadena, CA